Skip to main content

Table 2 Patient characteristics at initial diagnosis

From: Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer

  Number of patients = 51
Median age 67.5 (43–83)
PSA at initial presentation (%)
Range 3.8–360
<20 32 (62.7%)
>20 16 (31.3%)
Unknown 3 (5.8%)
Metachronous 43 (84.3%)
Synchronous 8 (15.7%)
Gleason grade grouping (%)
No biopsy available 5 (9.8%)
1 4 (7.8%)
2 4 (7.8%)
3 14 (27.5%)
4 6 (11.8%)
5 18 (35.3%)
ADT treatment at primary diagnosis
Yes 39 (76.5%)
No 12 (23.5%)
Primary tumour staging
Unknown 2 (3.9%)
T1 0
T2 10 (19.6%)
T3 38 (74.5%)
T4 1 (1.9%)
Nodal staging
Unknown 2 (3.9%)
N0 39 (76.5%)
N1 10 (19.6%)
Metastatic disease
M0 42 (82.4%)
M1 9 (17.6%)
Primary treatment
Radical prostatectomy alone 5 (9.8%)
Radical radiotherapy to prostate ± pelvic lymph nodes 23 (41.2%)
Radical prostatectomy and prostate bed ± pelvic lymph node radiotherapy 23 (39.2%)
Salvage cystoprostatectomy/pelvic exenteration 5 (9.8%)
Salvage HIFU 1 (1.9%)
  1. HIFU high intensity focused ultrasound